DEGARELIX

DEGARELIX was reported 5246 times

DEGARELIX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE PLAQUE 5 0.2381
1 TISSUE RUPTURE 6 0.1200
2 HORMONE-DEPENDENT PROSTATE CANCER 8 0.1176
3 IDIOPATHIC PANCREATITIS 4 0.1111
4 HYPOPARATHYROIDISM SECONDARY 7 0.0603
5 HOMOSEXUALITY 3 0.0492
6 PROSTATIC SPECIFIC ANTIGEN DECREASED 18 0.0480
7 NEUROENDOCRINE CARCINOMA OF PROSTATE 3 0.0469
8 APPARENT MINERALOCORTICOID EXCESS 2 0.0357
9 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 35 0.0339
10 MUCOCUTANEOUS DISORDER 5 0.0333
11 HYPERADRENALISM 4 0.0328
12 URETHRAL OBSTRUCTION 9 0.0223
13 CEREBRAL AMYLOID ANGIOPATHY 7 0.0219
14 BLOOD TESTOSTERONE ABNORMAL 24 0.0217
15 GASTROINTESTINAL ANASTOMOTIC STENOSIS 2 0.0211
16 SPINAL CORD INFARCTION 9 0.0208
17 INJECTION SITE CELLULITIS 37 0.0204
18 COLD-STIMULUS HEADACHE 6 0.0190
19 PROSTATE CANCER METASTATIC 62 0.0187
20 HORMONE-REFRACTORY PROSTATE CANCER 21 0.0181
21 NECROTISING RETINITIS 11 0.0175
22 RESPIRATORY MONILIASIS 4 0.0152
23 AUTONOMIC DYSREFLEXIA 2 0.0126
24 BLADDER CYST 2 0.0126
25 PROSTATIC SPECIFIC ANTIGEN INCREASED 165 0.0121
26 MENINGORRHAGIA 3 0.0120
27 POSTRENAL FAILURE 5 0.0114
28 BLOOD TESTOSTERONE INCREASED 24 0.0113
29 MALE SEXUAL DYSFUNCTION 6 0.0103
30 VENTRICULAR FAILURE 3 0.0096
31 PROSTATIC HAEMORRHAGE 3 0.0096
32 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 6 0.0094
33 CARDIAC PERFORATION 2 0.0088
34 URETEROLITHIASIS 8 0.0078
35 INJECTION SITE ABSCESS 19 0.0077
36 RETROPERITONEAL LYMPHADENOPATHY 4 0.0077
37 SCROTAL PAIN 4 0.0075
38 INJECTION SITE INDURATION 93 0.0073
39 BONE SCAN ABNORMAL 3 0.0071
40 ERYTHROPENIA 2 0.0067
41 RESPIRATORY TRACT INFLAMMATION 3 0.0065
42 EROSIVE DUODENITIS 5 0.0063
43 PENILE SIZE REDUCED 6 0.0063
44 ADMINISTRATION SITE SWELLING 2 0.0063
45 ABDOMINAL WALL ABSCESS 4 0.0062
46 HYPERCREATINAEMIA 2 0.0062
47 BLADDER OBSTRUCTION 3 0.0060
48 METASTASES TO BONE MARROW 3 0.0060
49 BONE NEOPLASM 6 0.0056
50 INJECTION SITE INFLAMMATION 26 0.0053
51 PROSTATE CANCER RECURRENT 3 0.0050
52 INJECTION SITE NODULE 53 0.0049
53 TESTICULAR SWELLING 6 0.0048
54 URINARY TRACT OBSTRUCTION 11 0.0047
55 TESTICULAR ATROPHY 4 0.0047
56 FEELINGS OF WORTHLESSNESS 6 0.0046
57 EXTRADURAL HAEMATOMA 6 0.0046
58 HOT FLUSH 327 0.0044
59 VASCULAR PURPURA 6 0.0044
60 VASOGENIC CEREBRAL OEDEMA 3 0.0043
61 METASTASES TO SPINE 14 0.0042
62 METASTASES TO BONE 68 0.0042
63 INJECTION SITE OEDEMA 7 0.0042
64 TRAUMATIC FRACTURE 3 0.0041
65 TESTICULAR DISORDER 4 0.0040
66 INDURATION 7 0.0040
67 KELOID SCAR 2 0.0040
68 BLOOD ALBUMIN ABNORMAL 2 0.0040
69 ACUTE INTERSTITIAL PNEUMONITIS 2 0.0039
70 FAECAL VOMITING 2 0.0038
71 LEFT ATRIAL ENLARGEMENT 2 0.0038
72 URETERIC STENOSIS 3 0.0038
73 GASTROENTERITIS SALMONELLA 3 0.0037
74 HELICOBACTER TEST POSITIVE 2 0.0036
75 INTRACRANIAL HAEMATOMA 2 0.0036
76 INJECTION SITE MASS 130 0.0036
77 ENCEPHALOMALACIA 2 0.0036
78 INJECTION SITE INFECTION 11 0.0034
79 CENTRAL SEROUS CHORIORETINOPATHY 2 0.0033
80 ONYCHOLYSIS 5 0.0033
81 SEDATION COMPLICATION 8 0.0032
82 WRONG SCHEDULE 3 0.0032
83 SPINAL COLUMN INJURY 7 0.0032
84 CANCER PAIN 8 0.0032
85 HEAT ILLNESS 2 0.0031
86 INJECTION SITE DISCOMFORT 31 0.0030
87 INFECTIOUS PERITONITIS 2 0.0029
88 WAIST CIRCUMFERENCE INCREASED 3 0.0029
89 TESTICULAR PAIN 9 0.0029
90 INJECTION SITE SWELLING 210 0.0028
91 DERMATOMYOSITIS 7 0.0028
92 ACUTE ABDOMEN 4 0.0028
93 LIP EROSION 2 0.0028
94 SECONDARY ADRENOCORTICAL INSUFFICIENCY 4 0.0027
95 UROSEPSIS 24 0.0026
96 METASTASES TO LYMPH NODES 17 0.0026
97 PRODUCT LEAKAGE 13 0.0025
98 INJECTION SITE WARMTH 50 0.0025
99 PERIPHERAL SENSORIMOTOR NEUROPATHY 3 0.0025
100 PRODUCT STORAGE ERROR 209 0.0024
101 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 4 0.0024
102 OSTEITIS 6 0.0024
103 INJECTION SITE ERYTHEMA 291 0.0024
104 PEMPHIGOID 17 0.0023
105 ABDOMINAL MASS 6 0.0023
106 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0023
107 LUNG CONSOLIDATION 6 0.0022
108 URINE FLOW DECREASED 5 0.0021
109 RADIOTHERAPY 4 0.0021
110 BLADDER TRANSITIONAL CELL CARCINOMA 3 0.0021
111 OSTEONECROSIS OF JAW 52 0.0021
112 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35 0.0021
113 RADIUS FRACTURE 5 0.0021
114 LEFT VENTRICULAR FAILURE 7 0.0021
115 SPINAL CORD COMPRESSION 8 0.0021
116 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0021
117 ADMINISTRATION SITE EXTRAVASATION 2 0.0021
118 ACQUIRED HAEMOPHILIA 2 0.0021
119 HYPOCALCAEMIA 38 0.0020
120 DROWNING 2 0.0020
121 FEMORAL NECK FRACTURE 10 0.0020
122 URINARY BLADDER HAEMORRHAGE 4 0.0019
123 PRODUCT PREPARATION ISSUE 11 0.0019
124 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
125 INJECTION RELATED REACTION 3 0.0019
126 ODYNOPHAGIA 11 0.0019
127 ABDOMINAL RIGIDITY 5 0.0019
128 PRODUCT LOT NUMBER ISSUE 4 0.0019
129 MONOPLEGIA 8 0.0019
130 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 33 0.0018
131 ABDOMINAL TENDERNESS 9 0.0018
132 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 2 0.0018
133 POST PROCEDURAL HAEMATOMA 3 0.0018
134 ADMINISTRATION SITE PAIN 2 0.0018
135 APLASIA PURE RED CELL 6 0.0018
136 BLOOD TESTOSTERONE DECREASED 12 0.0018
137 HEPATITIS FULMINANT 5 0.0017
138 BONE LESION 6 0.0017
139 MUSCLE FATIGUE 7 0.0017
140 HYDRONEPHROSIS 12 0.0016
141 AMPUTATION 2 0.0016
142 NOCTURIA 19 0.0016
143 OSTEOPOROTIC FRACTURE 3 0.0016
144 HYPOREFLEXIA 3 0.0016
145 LIPOMA 4 0.0016
146 ABDOMINAL WALL HAEMATOMA 3 0.0016
147 LISTLESS 5 0.0015
148 INTESTINAL DILATATION 2 0.0015
149 SYRINGE ISSUE 26 0.0015
150 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
151 CALCULUS BLADDER 2 0.0015
152 INJECTION SITE NECROSIS 3 0.0015
153 INTERCEPTED PRODUCT STORAGE ERROR 5 0.0015
154 CARDIOVERSION 2 0.0014
155 INJECTION SITE SCAR 4 0.0014
156 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
157 BLADDER DISORDER 14 0.0014
158 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
159 METASTASIS 10 0.0014
160 IMMUNOSUPPRESSION 12 0.0014
161 DISEASE PROGRESSION 162 0.0014
162 METASTASES TO LIVER 24 0.0014
163 INTERSTITIAL LUNG DISEASE 66 0.0014
164 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
165 CHOLANGIOCARCINOMA 2 0.0014
166 ISCHAEMIC STROKE 24 0.0014
167 INJECTION SITE REACTION 90 0.0013
168 PROSTATE CANCER 106 0.0013
169 INJECTION SITE HYPERSENSITIVITY 4 0.0013
170 LOCALISED OEDEMA 6 0.0013
171 FUNGAEMIA 2 0.0013
172 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0013
173 URINARY HESITATION 3 0.0013
174 GROIN PAIN 11 0.0013
175 INJECTION SITE PAIN 364 0.0012
176 FOOD AVERSION 2 0.0012
177 RETINAL DETACHMENT 11 0.0012
178 HAEMORRHAGE URINARY TRACT 3 0.0012
179 URINARY RETENTION 39 0.0012
180 COMPRESSION FRACTURE 6 0.0012
181 INTERCEPTED PRODUCT PREPARATION ERROR 14 0.0012
182 MUSCLE ATROPHY 14 0.0011
183 DERMATITIS BULLOUS 8 0.0011
184 POLYNEUROPATHY 13 0.0011
185 BONE PAIN 64 0.0011
186 ANAL HAEMORRHAGE 3 0.0011
187 PERSONALITY CHANGE 10 0.0011
188 TONGUE OEDEMA 4 0.0011
189 RESTLESS LEGS SYNDROME 19 0.0011
190 TERMINAL STATE 7 0.0011
191 HYPERTONIC BLADDER 3 0.0011
192 PRODUCT PREPARATION ERROR 21 0.0010
193 CHILLS 119 0.0010
194 HYPERAEMIA 2 0.0010
195 ERECTILE DYSFUNCTION 26 0.0010
196 BODY TEMPERATURE DECREASED 10 0.0010
197 GENE MUTATION 2 0.0010
198 LOSS OF LIBIDO 9 0.0010
199 BLOOD URINE PRESENT 19 0.0010
200 URINE ANALYSIS ABNORMAL 3 0.0010
201 DUODENAL ULCER 7 0.0010
202 TOXIC SKIN ERUPTION 10 0.0010
203 FOREIGN BODY IN THROAT 3 0.0010
204 CACHEXIA 5 0.0010
205 RECTAL CANCER 3 0.0010
206 AGRANULOCYTOSIS 18 0.0010
207 LIBIDO DECREASED 12 0.0010
208 FLANK PAIN 9 0.0010
209 RASH PUSTULAR 7 0.0010
210 FEBRILE BONE MARROW APLASIA 4 0.0010
211 MALIGNANT NEOPLASM PROGRESSION 97 0.0010
212 INJECTION SITE IRRITATION 12 0.0010
213 NON-CARDIAC CHEST PAIN 3 0.0010
214 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24 0.0010
215 SUDDEN DEATH 10 0.0009
216 OCCUPATIONAL EXPOSURE TO PRODUCT 6 0.0009
217 HYPERTHERMIA 7 0.0009
218 ABDOMINAL ABSCESS 4 0.0009
219 HAEMORRHAGIC ANAEMIA 4 0.0009
220 DYSURIA 33 0.0009
221 LICHENOID KERATOSIS 2 0.0009
222 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
223 HYPOKALAEMIA 40 0.0009
224 EYELID DISORDER 2 0.0009
225 LARGE INTESTINE POLYP 6 0.0009
226 HYPOMAGNESAEMIA 12 0.0009
227 AORTIC STENOSIS 3 0.0009
228 FEELING COLD 24 0.0009
229 CEREBRAL INFARCTION 21 0.0009
230 RASH MACULO-PAPULAR 19 0.0009
231 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
232 SKIN ABRASION 4 0.0009
233 EMBOLIC STROKE 3 0.0009
234 APHTHOUS STOMATITIS 2 0.0009
235 THROMBOPHLEBITIS 3 0.0009
236 ATAXIA 10 0.0009
237 SPINAL COMPRESSION FRACTURE 7 0.0008
238 HYPERKALAEMIA 29 0.0008
239 LONG QT SYNDROME 2 0.0008
240 INJECTION SITE RASH 25 0.0008
241 FAECAL INCONTINENCE 4 0.0008
242 FEELING DRUNK 6 0.0008
243 METASTASES TO PERITONEUM 2 0.0008
244 BLOOD CALCIUM INCREASED 7 0.0008
245 BRAIN INJURY 8 0.0008
246 MICTURITION URGENCY 9 0.0008
247 ERYSIPELAS 4 0.0008
248 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
249 ENDODONTIC PROCEDURE 2 0.0008
250 MASS 11 0.0008
251 HEPATIC FUNCTION ABNORMAL 29 0.0008
252 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
253 LUNG OPACITY 2 0.0008
254 HAEMATURIA 26 0.0008
255 CELLULITIS 38 0.0008
256 SKIN MASS 5 0.0008
257 DYSSTASIA 22 0.0008
258 CORONAVIRUS INFECTION 5 0.0008
259 AZOTAEMIA 3 0.0008
260 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
261 CARDIAC FAILURE 59 0.0007
262 SMALL INTESTINAL OBSTRUCTION 9 0.0007
263 GOUT 13 0.0007
264 POLLAKIURIA 30 0.0007
265 HAEMORRHOIDS 14 0.0007
266 INTESTINAL STENOSIS 3 0.0007
267 MUSCULOSKELETAL CHEST PAIN 11 0.0007
268 BLOOD CALCIUM DECREASED 8 0.0007
269 FACIAL PARALYSIS 6 0.0007
270 EXERCISE TOLERANCE DECREASED 4 0.0007
271 PYELONEPHRITIS 6 0.0007
272 OCULAR ICTERUS 3 0.0007
273 DYSPNOEA AT REST 2 0.0007
274 PLATELET COUNT INCREASED 9 0.0007
275 DIVERTICULUM INTESTINAL 3 0.0007
276 APATHY 10 0.0007
277 BONE CANCER 3 0.0007
278 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
279 BODY TEMPERATURE INCREASED 14 0.0007
280 COLD SWEAT 12 0.0007
281 ADVERSE REACTION 9 0.0007
282 ANAL INCONTINENCE 6 0.0007
283 HAEMATEMESIS 17 0.0007
284 HALLUCINATION, VISUAL 14 0.0007
285 INJECTION SITE VESICLES 4 0.0007
286 ANAPHYLACTIC SHOCK 17 0.0007
287 DYSAESTHESIA 2 0.0007
288 RESPIRATORY DEPRESSION 8 0.0007
289 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0007
290 CHEST X-RAY ABNORMAL 2 0.0007
291 GENERAL PHYSICAL HEALTH DETERIORATION 74 0.0007
292 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0007
293 INFUSION SITE EXTRAVASATION 4 0.0007
294 GASTROINTESTINAL INFLAMMATION 5 0.0007
295 COORDINATION ABNORMAL 9 0.0006
296 YELLOW SKIN 3 0.0006
297 BLOOD CREATININE DECREASED 2 0.0006
298 SYNCOPE 64 0.0006
299 HYPERHIDROSIS 82 0.0006
300 INVESTIGATION 2 0.0006
301 STEVENS-JOHNSON SYNDROME 14 0.0006
302 RENAL CYST 5 0.0006
303 HYPERCHOLESTEROLAEMIA 6 0.0006
304 HYPERTENSIVE CRISIS 7 0.0006
305 ORAL MUCOSAL BLISTERING 4 0.0006
306 HUMERUS FRACTURE 3 0.0006
307 MOUTH ULCERATION 13 0.0006
308 INCOHERENT 4 0.0006
309 HEPATIC NEOPLASM 2 0.0006
310 INTENTIONAL DRUG MISUSE 13 0.0006
311 ORGANISING PNEUMONIA 3 0.0006
312 BREAST ENLARGEMENT 2 0.0006
313 METASTASES TO LUNG 7 0.0006
314 STAPHYLOCOCCAL SEPSIS 3 0.0006
315 WALKING AID USER 4 0.0006
316 PRODUCT ADMINISTRATION ERROR 12 0.0006
317 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
318 RHABDOMYOLYSIS 25 0.0006
319 TASTE DISORDER 12 0.0006
320 CEREBRAL HAEMATOMA 2 0.0006
321 COLITIS ISCHAEMIC 4 0.0006
322 CORONARY ARTERIAL STENT INSERTION 3 0.0006
323 PATHOLOGICAL FRACTURE 3 0.0006
324 DYSLIPIDAEMIA 3 0.0006
325 ASTHENIA 222 0.0006
326 TOOTH ABSCESS 6 0.0006
327 PHLEBITIS 3 0.0006
328 CERVICAL VERTEBRAL FRACTURE 2 0.0006
329 HYPOPNOEA 2 0.0006
330 CATATONIA 3 0.0006
331 SERUM FERRITIN INCREASED 3 0.0006
332 URINE OUTPUT DECREASED 5 0.0006
333 JOINT DISLOCATION 6 0.0006
334 CAROTID ARTERY STENOSIS 2 0.0006
335 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0006
336 NYSTAGMUS 3 0.0006
337 JAUNDICE CHOLESTATIC 2 0.0006
338 LYMPHADENOPATHY 20 0.0006
339 LIVER DISORDER 25 0.0006
340 PRODUCT SIZE ISSUE 3 0.0006
341 FIBRIN D DIMER INCREASED 2 0.0006
342 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
343 INTESTINAL RESECTION 3 0.0006
344 FACIAL PAIN 5 0.0006
345 DECREASED ACTIVITY 6 0.0006
346 NIGHT SWEATS 18 0.0006
347 GINGIVITIS 3 0.0006
348 BRAIN OEDEMA 7 0.0006
349 VISUAL FIELD DEFECT 4 0.0006
350 PRODUCT PACKAGING QUANTITY ISSUE 6 0.0006
351 PELVIC PAIN 10 0.0006
352 CAROTID ARTERY OCCLUSION 2 0.0006
353 BACK PAIN 127 0.0006
354 HYPOPHOSPHATAEMIA 4 0.0006
355 GAIT INABILITY 18 0.0006
356 FEBRILE NEUTROPENIA 36 0.0006
357 VENTRICULAR TACHYCARDIA 9 0.0006
358 CHEMOTHERAPY 2 0.0005
359 LETHARGY 31 0.0005
360 PANCREATITIS ACUTE 12 0.0005
361 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
362 GASTRIC ULCER HAEMORRHAGE 3 0.0005
363 CATHETER SITE INFECTION 2 0.0005
364 BEDRIDDEN 7 0.0005
365 AUTOIMMUNE THYROIDITIS 2 0.0005
366 DECREASED APPETITE 123 0.0005
367 HEPATIC NECROSIS 2 0.0005
368 FACE INJURY 2 0.0005
369 ARRHYTHMIA 25 0.0005
370 HEPATOCELLULAR CARCINOMA 4 0.0005
371 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
372 MUSCULOSKELETAL DISCOMFORT 9 0.0005
373 AORTIC ANEURYSM 4 0.0005
374 FATIGUE 405 0.0005
375 CLAVICLE FRACTURE 2 0.0005
376 QUALITY OF LIFE DECREASED 7 0.0005
377 CORONARY ARTERY BYPASS 3 0.0005
378 SPINAL PAIN 6 0.0005
379 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
380 CORONARY ARTERY OCCLUSION 7 0.0005
381 INFLAMMATION 26 0.0005
382 BLOOD PRESSURE ABNORMAL 10 0.0005
383 HAEMATOCRIT DECREASED 10 0.0005
384 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
385 FUNGAL SKIN INFECTION 2 0.0005
386 ANAEMIA 95 0.0005
387 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
388 SENSORY LOSS 4 0.0005
389 SHOCK HAEMORRHAGIC 4 0.0005
390 HEPATIC CYTOLYSIS 6 0.0005
391 ABDOMINAL DISTENSION 51 0.0005
392 INITIAL INSOMNIA 5 0.0005
393 BONE DISORDER 9 0.0005
394 ASPHYXIA 4 0.0005
395 ANAPHYLACTOID REACTION 2 0.0005
396 PYREXIA 169 0.0005
397 HYPERURICAEMIA 2 0.0005
398 FALL 161 0.0005
399 INFLUENZA LIKE ILLNESS 40 0.0005
400 OSTEONECROSIS 16 0.0005
401 HYPERPYREXIA 2 0.0005
402 SECOND PRIMARY MALIGNANCY 4 0.0005
403 AORTIC DISSECTION 2 0.0005
404 ACUTE CORONARY SYNDROME 4 0.0005
405 DISORIENTATION 19 0.0005
406 INJECTION SITE HAEMATOMA 7 0.0005
407 TRANSFUSION 5 0.0005
408 MOBILITY DECREASED 34 0.0005
409 URINARY INCONTINENCE 14 0.0005
410 DEHYDRATION 63 0.0005
411 FACE OEDEMA 8 0.0005
412 INCONTINENCE 5 0.0005
413 INCORRECT ROUTE OF DRUG ADMINISTRATION 17 0.0005
414 HAEMOGLOBIN ABNORMAL 3 0.0005
415 LOSS OF CONSCIOUSNESS 60 0.0005
416 UNRESPONSIVE TO STIMULI 12 0.0005
417 BLOOD POTASSIUM DECREASED 14 0.0005
418 ABDOMINAL PAIN 108 0.0005
419 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
420 HEPATITIS ACUTE 3 0.0005
421 NODULE 6 0.0005
422 IMMOBILE 2 0.0005
423 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
424 ANGINA UNSTABLE 3 0.0005
425 PERIPHERAL SWELLING 70 0.0005
426 CARDIAC FAILURE ACUTE 3 0.0005
427 INJECTION SITE PRURITUS 30 0.0005
428 ANGINA PECTORIS 13 0.0005
429 ILEUS PARALYTIC 2 0.0005
430 RESPIRATORY RATE INCREASED 4 0.0005
431 MUSCULAR WEAKNESS 51 0.0005
432 PRODUCT LABEL ISSUE 3 0.0005
433 GYNAECOMASTIA 14 0.0005
434 BRAIN NEOPLASM MALIGNANT 2 0.0005
435 DIABETES MELLITUS 34 0.0004
436 HAEMOGLOBIN INCREASED 2 0.0004
437 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
438 ATRIAL FIBRILLATION 43 0.0004
439 ACUTE KIDNEY INJURY 67 0.0004
440 PALLOR 12 0.0004
441 ABASIA 11 0.0004
442 NEPHROTIC SYNDROME 3 0.0004
443 BLOOD PRESSURE DECREASED 29 0.0004
444 LYMPHOEDEMA 3 0.0004
445 INFARCTION 3 0.0004
446 NERVE COMPRESSION 4 0.0004
447 LARGE INTESTINE PERFORATION 3 0.0004
448 DEVICE OCCLUSION 6 0.0004
449 CEREBROVASCULAR ACCIDENT 73 0.0004
450 ERYTHEMA MULTIFORME 4 0.0004
451 PULMONARY TOXICITY 3 0.0004
452 INCREASED APPETITE 8 0.0004
453 CONSTIPATION 92 0.0004
454 PRODUCT SUPPLY ISSUE 3 0.0004
455 LIMB DISCOMFORT 13 0.0004
456 CARDIAC TAMPONADE 2 0.0004
457 CANDIDA INFECTION 7 0.0004
458 RED BLOOD CELL COUNT DECREASED 12 0.0004
459 CHOLESTASIS 8 0.0004
460 PULMONARY EMBOLISM 40 0.0004
461 HAEMOGLOBIN DECREASED 43 0.0004
462 ADRENAL INSUFFICIENCY 5 0.0004
463 URINARY TRACT INFECTION 71 0.0004
464 MUSCULOSKELETAL PAIN 22 0.0004
465 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
466 VERTIGO 25 0.0004
467 APHAGIA 2 0.0004
468 DUODENAL ULCER PERFORATION 3 0.0004
469 PNEUMONITIS 11 0.0004
470 CYSTITIS 13 0.0004
471 RENAL TUBULAR NECROSIS 4 0.0004
472 HOSPICE CARE 4 0.0004
473 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
474 ACUTE MYOCARDIAL INFARCTION 12 0.0004
475 HIP FRACTURE 13 0.0004
476 THROMBOCYTOPENIA 45 0.0004
477 INJECTION SITE DISCOLOURATION 5 0.0004
478 HYPERNATRAEMIA 2 0.0004
479 COLON CANCER 6 0.0004
480 TOOTH EXTRACTION 5 0.0004
481 UPPER LIMB FRACTURE 8 0.0004
482 DISSOCIATION 3 0.0004
483 DRUG ERUPTION 7 0.0004
484 HEPATIC FAILURE 12 0.0004
485 HEART RATE DECREASED 14 0.0004
486 CORONARY ARTERY STENOSIS 2 0.0004
487 PRODUCT USE ISSUE 74 0.0004
488 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
489 DEMENTIA 11 0.0004
490 RENAL FAILURE ACUTE 17 0.0004
491 HYPOPHAGIA 10 0.0004
492 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
493 STAPHYLOCOCCAL INFECTION 13 0.0004
494 OEDEMA PERIPHERAL 48 0.0004
495 EXPIRED PRODUCT ADMINISTERED 13 0.0004
496 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
497 RIB FRACTURE 8 0.0004
498 MYALGIA 66 0.0004
499 HYPERBILIRUBINAEMIA 4 0.0004
500 PRODUCT USE COMPLAINT 6 0.0004
501 GASTROENTERITIS VIRAL 7 0.0004
502 FEMUR FRACTURE 12 0.0004
503 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
504 HYPERGLYCAEMIA 14 0.0004
505 CEREBRAL ISCHAEMIA 2 0.0004
506 FAILURE TO THRIVE 2 0.0004
507 CONFUSIONAL STATE 62 0.0004
508 TORSADE DE POINTES 3 0.0004
509 HALLUCINATION, AUDITORY 6 0.0004
510 PANCYTOPENIA 21 0.0004
511 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
512 RETCHING 8 0.0004
513 BREAST PAIN 4 0.0004
514 ANAL ABSCESS 2 0.0004
515 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
516 INJECTION SITE URTICARIA 9 0.0004
517 MENTAL IMPAIRMENT 9 0.0004
518 NEUROPATHY PERIPHERAL 35 0.0004
519 BODY HEIGHT DECREASED 4 0.0004
520 BALANCE DISORDER 32 0.0004
521 NEUTROPENIA 50 0.0004
522 POLYURIA 3 0.0004
523 DRUG INTERACTION 58 0.0004
524 HYPOTENSION 73 0.0004
525 HERNIA 7 0.0004
526 APHASIA 11 0.0004
527 PERIPHERAL COLDNESS 5 0.0004
528 HEMIPLEGIA 3 0.0004
529 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
530 ACUTE PULMONARY OEDEMA 2 0.0004
531 INTESTINAL HAEMORRHAGE 2 0.0004
532 CHOLECYSTITIS ACUTE 2 0.0004
533 MITRAL VALVE INCOMPETENCE 4 0.0004
534 SWELLING 33 0.0004
535 SKIN SWELLING 3 0.0004
536 AMNESIA 23 0.0004
537 HEPATOCELLULAR INJURY 5 0.0004
538 PRESCRIBED UNDERDOSE 7 0.0004
539 SHOCK 8 0.0004
540 VITAMIN D DECREASED 3 0.0004
541 WEIGHT INCREASED 78 0.0004
542 SEPSIS 39 0.0004
543 HYPERSOMNIA 10 0.0004
544 GRANULOCYTOPENIA 2 0.0004
545 PARALYSIS 5 0.0004
546 ELECTROLYTE IMBALANCE 4 0.0004
547 BLOOD MAGNESIUM DECREASED 3 0.0004
548 NEOPLASM 4 0.0004
549 SEPTIC SHOCK 15 0.0004
550 DYSPNOEA EXERTIONAL 13 0.0004
551 MYOPATHY 3 0.0004
552 MUSCLE TWITCHING 8 0.0004
553 MUCOSAL INFLAMMATION 9 0.0003
554 CARDIAC MURMUR 3 0.0003
555 RASH MACULAR 12 0.0003
556 EOSINOPHILIA 6 0.0003
557 UNDERDOSE 25 0.0003
558 MYOCARDIAL INFARCTION 60 0.0003
559 HYPOAESTHESIA 51 0.0003
560 INCORRECT DOSE ADMINISTERED 76 0.0003
561 CATARACT OPERATION 2 0.0003
562 INSURANCE ISSUE 5 0.0003
563 HYPERLIPIDAEMIA 4 0.0003
564 BLOOD BILIRUBIN INCREASED 9 0.0003
565 OSTEOMYELITIS 6 0.0003
566 PRESYNCOPE 8 0.0003
567 NEURALGIA 8 0.0003
568 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
569 ILEUS 4 0.0003
570 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
571 DRUG-INDUCED LIVER INJURY 10 0.0003
572 DEVICE RELATED INFECTION 5 0.0003
573 CHEST PAIN 60 0.0003
574 PNEUMONIA ASPIRATION 8 0.0003
575 NEUTROPHIL COUNT DECREASED 13 0.0003
576 INJECTION SITE EXTRAVASATION 4 0.0003
577 AGEUSIA 8 0.0003
578 ARTHRALGIA 132 0.0003
579 ARTERIOSCLEROSIS 3 0.0003
580 FRACTURE 6 0.0003
581 SPINAL DISORDER 3 0.0003
582 SCIATICA 5 0.0003
583 ENTERITIS 2 0.0003
584 WEIGHT DECREASED 87 0.0003
585 MOVEMENT DISORDER 10 0.0003
586 BLOOD POTASSIUM INCREASED 5 0.0003
587 CEREBRAL HAEMORRHAGE 11 0.0003
588 DIZZINESS 151 0.0003
589 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
590 CARDIAC ARREST 25 0.0003
591 FEEDING DISORDER 6 0.0003
592 GAIT DISTURBANCE 57 0.0003
593 EMPHYSEMA 3 0.0003
594 PRODUCT PRESCRIBING ERROR 7 0.0003
595 TACHYPNOEA 4 0.0003
596 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
597 BLOOD PRESSURE INCREASED 45 0.0003
598 THERAPY CESSATION 15 0.0003
599 LUNG NEOPLASM MALIGNANT 12 0.0003
600 SCRATCH 3 0.0003
601 PERITONITIS 6 0.0003
602 INSOMNIA 77 0.0003
603 ERYTHEMA 59 0.0003
604 TENDERNESS 3 0.0003
605 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
606 FULL BLOOD COUNT ABNORMAL 3 0.0003
607 SKIN REACTION 4 0.0003
608 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
609 HAND FRACTURE 2 0.0003
610 MALAISE 124 0.0003
611 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
612 THIRST 5 0.0003
613 DISCOMFORT 17 0.0003
614 PLEURAL EFFUSION 17 0.0003
615 RECTAL HAEMORRHAGE 12 0.0003
616 SKIN LACERATION 3 0.0003
617 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 56 0.0003
618 FEELING HOT 17 0.0003
619 SWELLING FACE 18 0.0003
620 LEUKOCYTOSIS 5 0.0003
621 FAECES SOFT 2 0.0003
622 TREATMENT NONCOMPLIANCE 15 0.0003
623 WOUND INFECTION 3 0.0003
624 HYPOKINESIA 4 0.0003
625 RENAL IMPAIRMENT 23 0.0003
626 BRAIN FOG 4 0.0003
627 HYPERTENSION 58 0.0003
628 HAEMATOCHEZIA 15 0.0003
629 TOOTH FRACTURE 3 0.0003
630 MELAENA 6 0.0003
631 HEPATOTOXICITY 6 0.0003
632 TACHYCARDIA 24 0.0003
633 TRANSAMINASES INCREASED 6 0.0003
634 BLOOD GLUCOSE ABNORMAL 5 0.0003
635 MALNUTRITION 3 0.0003
636 DIPLOPIA 7 0.0003
637 HAEMATOMA 7 0.0003
638 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
639 OSTEOPOROSIS 11 0.0003
640 HAEMODYNAMIC INSTABILITY 2 0.0003
641 FISTULA 3 0.0003
642 GASTRITIS 7 0.0003
643 HEPATIC ENZYME INCREASED 18 0.0003
644 SCAB 3 0.0003
645 URTICARIA 44 0.0003
646 IMPAIRED DRIVING ABILITY 3 0.0003
647 HIP ARTHROPLASTY 4 0.0003
648 BOWEL MOVEMENT IRREGULARITY 2 0.0003
649 LIPASE INCREASED 2 0.0003
650 RENAL FAILURE 35 0.0003
651 HYPOALBUMINAEMIA 2 0.0003
652 ACIDOSIS 2 0.0003
653 THERAPY INTERRUPTED 18 0.0003
654 PAIN IN EXTREMITY 77 0.0003
655 LEUKOPENIA 13 0.0003
656 DEVICE LEAKAGE 11 0.0003
657 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
658 RASH PRURITIC 14 0.0003
659 OEDEMA 14 0.0003
660 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
661 HAEMOLYSIS 2 0.0003
662 COGNITIVE DISORDER 12 0.0003
663 INFUSION RELATED REACTION 17 0.0003
664 INTENTIONAL DOSE OMISSION 7 0.0003
665 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
666 FURUNCLE 2 0.0003
667 MOOD SWINGS 8 0.0003
668 MUSCLE SPASMS 46 0.0003
669 GASTROINTESTINAL DISORDER 22 0.0003
670 INJURY ASSOCIATED WITH DEVICE 5 0.0003
671 PARAESTHESIA 39 0.0003
672 DEPRESSED MOOD 13 0.0003
673 RESPIRATORY FAILURE 18 0.0002
674 ESCHERICHIA INFECTION 2 0.0002
675 PLATELET COUNT DECREASED 26 0.0002
676 ABNORMAL FAECES 2 0.0002
677 HYPERCALCAEMIA 3 0.0002
678 SLEEP DISORDER 17 0.0002
679 DEATH 209 0.0002
680 HYPERAESTHESIA 2 0.0002
681 DERMATITIS ALLERGIC 3 0.0002
682 SKIN EXFOLIATION 20 0.0002
683 EOSINOPHIL COUNT INCREASED 2 0.0002
684 EMBOLISM 2 0.0002
685 LIVER FUNCTION TEST ABNORMAL 7 0.0002
686 PAIN 147 0.0002
687 PSYCHOTIC DISORDER 7 0.0002
688 TYPE 2 DIABETES MELLITUS 8 0.0002
689 ABDOMINAL PAIN LOWER 6 0.0002
690 CATARACT 14 0.0002
691 BLOOD CHOLESTEROL INCREASED 11 0.0002
692 OSTEOARTHRITIS 10 0.0002
693 HEPATITIS 6 0.0002
694 CARDIAC FAILURE CONGESTIVE 19 0.0002
695 GASTRIC CANCER 6 0.0002
696 EATING DISORDER 5 0.0002
697 POOR QUALITY SLEEP 5 0.0002
698 DYSPNOEA 132 0.0002
699 NECK PAIN 13 0.0002
700 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
701 DELIRIUM 8 0.0002
702 ORTHOSTATIC HYPOTENSION 4 0.0002
703 TREMOR 38 0.0002
704 RASH GENERALISED 6 0.0002
705 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
706 NEOPLASM PROGRESSION 8 0.0002
707 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
708 DRUG ADMINISTRATION ERROR 7 0.0002
709 SWOLLEN TONGUE 7 0.0002
710 ADVERSE DRUG REACTION 20 0.0002
711 PRODUCT AVAILABILITY ISSUE 5 0.0002
712 CHROMATURIA 5 0.0002
713 TOOTHACHE 4 0.0002
714 C-REACTIVE PROTEIN INCREASED 8 0.0002
715 ACCIDENTAL OVERDOSE 8 0.0002
716 CONTUSION 21 0.0002
717 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
718 RASH 94 0.0002
719 MENTAL STATUS CHANGES 6 0.0002
720 ABNORMAL DREAMS 6 0.0002
721 BACTERIAL INFECTION 4 0.0002
722 MIDDLE INSOMNIA 4 0.0002
723 HEPATIC STEATOSIS 4 0.0002
724 BLOOD CREATININE INCREASED 14 0.0002
725 BLOOD TEST ABNORMAL 3 0.0002
726 CARPAL TUNNEL SYNDROME 3 0.0002
727 PNEUMONIA 69 0.0002
728 LYMPHOPENIA 3 0.0002
729 BLOOD SODIUM DECREASED 4 0.0002
730 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
731 SINUS TACHYCARDIA 3 0.0002
732 NEOPLASM MALIGNANT 14 0.0002
733 PULMONARY FIBROSIS 4 0.0002
734 MUSCULOSKELETAL DISORDER 4 0.0002
735 DIZZINESS POSTURAL 2 0.0002
736 SKIN HAEMORRHAGE 3 0.0002
737 POST PROCEDURAL COMPLICATION 4 0.0002
738 LIVER INJURY 5 0.0002
739 ANGIOEDEMA 9 0.0002
740 MEMORY IMPAIRMENT 28 0.0002
741 ABDOMINAL DISCOMFORT 34 0.0002
742 PULMONARY MASS 3 0.0002
743 SPINAL FRACTURE 4 0.0002
744 PRODUCT USE IN UNAPPROVED INDICATION 49 0.0002
745 ANAPHYLACTIC REACTION 11 0.0002
746 EPISTAXIS 15 0.0002
747 HYPOTONIA 2 0.0002
748 THERAPY PARTIAL RESPONDER 3 0.0002
749 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
750 HYPOAESTHESIA ORAL 3 0.0002
751 SOMNOLENCE 40 0.0002
752 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
753 VOMITING 93 0.0002
754 FULL BLOOD COUNT DECREASED 4 0.0002
755 UNEVALUABLE EVENT 15 0.0002
756 DRY THROAT 2 0.0002
757 DEPRESSION 45 0.0002
758 EPILEPSY 6 0.0002
759 EAR DISCOMFORT 2 0.0002
760 THYROID DISORDER 3 0.0002
761 LYMPHOMA 3 0.0002
762 PRURITUS 73 0.0002
763 ACUTE MYELOID LEUKAEMIA 3 0.0002
764 RASH ERYTHEMATOUS 9 0.0002
765 HERPES ZOSTER 11 0.0002
766 HEREDITARY ANGIOEDEMA 2 0.0002
767 CYANOSIS 3 0.0002
768 ABDOMINAL PAIN UPPER 39 0.0002
769 PANCREATITIS 10 0.0002
770 ULCER 3 0.0002
771 BRADYCARDIA 10 0.0002
772 ABSCESS 3 0.0002
773 LIVER FUNCTION TEST INCREASED 4 0.0002
774 DYSARTHRIA 7 0.0002
775 SENSORY DISTURBANCE 3 0.0002
776 HYPOGLYCAEMIA 9 0.0002
777 BURNING SENSATION 13 0.0002
778 JAUNDICE 5 0.0002
779 NAUSEA 146 0.0002
780 BACK INJURY 2 0.0002
781 BLADDER CANCER 11 0.0002
782 FAECES DISCOLOURED 4 0.0002
783 MANIA 3 0.0002
784 PRODUCT DOSE OMISSION 12 0.0002
785 RESPIRATORY DISTRESS 5 0.0002
786 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
787 WOUND 5 0.0002
788 DYSPHAGIA 17 0.0002
789 TOOTH DISORDER 4 0.0002
790 BLOOD UREA INCREASED 3 0.0002
791 RASH PAPULAR 4 0.0002
792 INTESTINAL PERFORATION 2 0.0002
793 HYPONATRAEMIA 10 0.0002
794 FLUID RETENTION 9 0.0002
795 FLATULENCE 10 0.0002
796 ANGER 6 0.0002
797 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
798 PAIN IN JAW 5 0.0002
799 HEMIPARESIS 3 0.0002
800 DIARRHOEA 113 0.0002
801 CIRCULATORY COLLAPSE 3 0.0002
802 NEEDLE ISSUE 5 0.0002
803 INTERNAL HAEMORRHAGE 2 0.0002
804 SEIZURE 20 0.0002
805 SKIN DISCOLOURATION 8 0.0002
806 PANCREATIC CARCINOMA 5 0.0002
807 NERVOUSNESS 9 0.0002
808 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
809 EYELID OEDEMA 2 0.0002
810 ASCITES 5 0.0002
811 BLOOD IRON DECREASED 2 0.0002
812 LYMPHOCYTE COUNT DECREASED 3 0.0002
813 LABORATORY TEST ABNORMAL 5 0.0002
814 FLUSHING 17 0.0002
815 FEELING ABNORMAL 40 0.0002
816 JOINT SWELLING 20 0.0002
817 THERAPEUTIC RESPONSE DECREASED 10 0.0002
818 LOCALISED INFECTION 4 0.0002
819 HEPATIC CANCER 4 0.0002
820 ILL-DEFINED DISORDER 10 0.0002
821 INJECTION SITE HAEMORRHAGE 13 0.0002
822 OFF LABEL USE 142 0.0002
823 EMOTIONAL DISORDER 5 0.0002
824 VISION BLURRED 22 0.0002
825 DYSGEUSIA 12 0.0002
826 INTESTINAL OBSTRUCTION 6 0.0002
827 HALLUCINATION 12 0.0002
828 INFECTION 23 0.0002
829 COLITIS 6 0.0002
830 METABOLIC ACIDOSIS 5 0.0002
831 LOWER LIMB FRACTURE 3 0.0002
832 CHEST DISCOMFORT 16 0.0002
833 ACUTE RESPIRATORY FAILURE 3 0.0002
834 DRUG RESISTANCE 4 0.0002
835 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
836 PRODUCT DOSE OMISSION ISSUE 44 0.0002
837 CHOKING 3 0.0002
838 ORAL HERPES 3 0.0002
839 BLOOD GLUCOSE INCREASED 29 0.0002
840 KIDNEY INFECTION 3 0.0002
841 SPEECH DISORDER 8 0.0002
842 DEAFNESS 4 0.0002
843 IMMUNE SYSTEM DISORDER 2 0.0002
844 DISABILITY 3 0.0002
845 HEART RATE INCREASED 15 0.0002
846 LIP SWELLING 5 0.0002
847 JOINT RANGE OF MOTION DECREASED 2 0.0002
848 DRY MOUTH 12 0.0002
849 MYELOSUPPRESSION 5 0.0001
850 HEADACHE 92 0.0001
851 CONDITION AGGRAVATED 44 0.0001
852 HOSPITALISATION 22 0.0001
853 ROAD TRAFFIC ACCIDENT 6 0.0001
854 IRRITABLE BOWEL SYNDROME 3 0.0001
855 HYPERSENSITIVITY 26 0.0001
856 AGGRESSION 7 0.0001
857 CARDIAC DISORDER 13 0.0001
858 CONVULSION 8 0.0001
859 GASTROENTERITIS 2 0.0001
860 MENINGIOMA 2 0.0001
861 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
862 RESPIRATORY DISORDER 4 0.0001
863 HAEMORRHAGE INTRACRANIAL 2 0.0001
864 RENAL INJURY 4 0.0001
865 IRRITABILITY 8 0.0001
866 BONE LOSS 2 0.0001
867 NEPHROLITHIASIS 6 0.0001
868 CORONARY ARTERY DISEASE 4 0.0001
869 BLOOD COUNT ABNORMAL 2 0.0001
870 EJECTION FRACTION DECREASED 2 0.0001
871 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
872 BASAL CELL CARCINOMA 2 0.0001
873 INJECTION SITE BRUISING 10 0.0001
874 HEAD INJURY 4 0.0001
875 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
876 ABNORMAL BEHAVIOUR 5 0.0001
877 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
878 LACTIC ACIDOSIS 4 0.0001
879 COVID-19 22 0.0001
880 BLINDNESS 5 0.0001
881 LUNG DISORDER 6 0.0001
882 ENCEPHALOPATHY 3 0.0001
883 DEEP VEIN THROMBOSIS 8 0.0001
884 AGITATION 9 0.0001
885 EYE DISORDER 4 0.0001
886 VISUAL IMPAIRMENT 15 0.0001
887 SURGERY 7 0.0001
888 PALPITATIONS 14 0.0001
889 ADVERSE EVENT 11 0.0001
890 RESPIRATORY TRACT INFECTION 3 0.0001
891 STOMATITIS 7 0.0001
892 NIGHTMARE 4 0.0001
893 DRY SKIN 15 0.0001
894 LOCAL SWELLING 2 0.0001
895 ALOPECIA 22 0.0001
896 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
897 MOOD ALTERED 3 0.0001
898 SKIN LESION 3 0.0001
899 END STAGE RENAL DISEASE 2 0.0001
900 RESPIRATORY ARREST 3 0.0001
901 ARTHROPATHY 6 0.0001
902 DRUG DOSE OMISSION 18 0.0001
903 INFLUENZA 12 0.0001
904 HAEMOPTYSIS 3 0.0001
905 RENAL DISORDER 5 0.0001
906 BLISTER 6 0.0001
907 HEPATIC CIRRHOSIS 2 0.0001
908 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
909 GLAUCOMA 2 0.0001
910 DYSPHONIA 6 0.0001
911 MUSCULOSKELETAL STIFFNESS 9 0.0001
912 DRUG PRESCRIBING ERROR 2 0.0001
913 WHEEZING 6 0.0001
914 ECZEMA 5 0.0001
915 SUICIDE ATTEMPT 6 0.0001
916 DYSKINESIA 4 0.0001
917 SUICIDAL IDEATION 9 0.0001
918 NERVOUS SYSTEM DISORDER 3 0.0001
919 CARDIO-RESPIRATORY ARREST 4 0.0001
920 WITHDRAWAL SYNDROME 4 0.0001
921 DRUG INTOLERANCE 9 0.0001
922 HYPOACUSIS 4 0.0001
923 RHINORRHOEA 6 0.0001
924 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
925 DYSPEPSIA 9 0.0001
926 CHOLELITHIASIS 3 0.0001
927 SKIN DISORDER 3 0.0001
928 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
929 MEDICATION ERROR 5 0.0001
930 THERAPY NON-RESPONDER 4 0.0001
931 OXYGEN SATURATION DECREASED 5 0.0001
932 VISUAL ACUITY REDUCED 3 0.0001
933 ARTHRITIS 7 0.0001
934 EXPOSURE VIA SKIN CONTACT 2 0.0001
935 HEART RATE IRREGULAR 2 0.0001
936 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
937 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
938 HAEMORRHAGE 9 0.0001
939 COUGH 24 0.0001
940 HYPOXIA 3 0.0001
941 NASAL CONGESTION 5 0.0001
942 TREATMENT FAILURE 7 0.0001
943 NO ADVERSE EVENT 15 0.0001
944 OVERDOSE 18 0.0001
945 BLOOD PRESSURE FLUCTUATION 2 0.0001
946 RENAL CANCER 4 0.0001
947 PANIC ATTACK 3 0.0001
948 RESTLESSNESS 3 0.0001
949 NASOPHARYNGITIS 15 0.0001
950 EYE SWELLING 3 0.0001
951 INTENTIONAL PRODUCT MISUSE 7 0.0001
952 CARDIOVASCULAR DISORDER 2 0.0001
953 ANXIETY 22 0.0001
954 JOINT STIFFNESS 2 0.0001
955 ANHEDONIA 2 0.0001
956 DISTURBANCE IN ATTENTION 4 0.0001
957 FEAR 2 0.0001
958 DIVERTICULITIS 2 0.0001
959 DRUG INEFFECTIVE 93 0.0001
960 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
961 MENTAL DISORDER 3 0.0001
962 THROAT IRRITATION 3 0.0001
963 LACRIMATION INCREASED 2 0.0001
964 DRUG HYPERSENSITIVITY 13 0.0001
965 PULMONARY OEDEMA 3 0.0001
966 SKIN IRRITATION 3 0.0001
967 TINNITUS 3 0.0001
968 OCULAR HYPERAEMIA 3 0.0001
969 PRODUCTIVE COUGH 3 0.0001
970 BONE DENSITY DECREASED 2 0.0001
971 COMA 3 0.0001
972 THROMBOSIS 5 0.0001
973 DEVICE MALFUNCTION 4 0.0001
974 SINUSITIS 6 0.0001
975 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
976 GASTRIC DISORDER 2 0.0001
977 STRESS 4 0.0001
978 DRUG EFFECT DECREASED 3 0.0001
979 OROPHARYNGEAL PAIN 5 0.0001
980 CHRONIC KIDNEY DISEASE 4 0.0001
981 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0001
982 ILLNESS 5 0.0001
983 DEVICE ISSUE 4 0.0000
984 BLOOD GLUCOSE DECREASED 2 0.0000
985 DRY EYE 2 0.0000
986 BRONCHITIS 3 0.0000
987 ACNE 3 0.0000
988 PRODUCT QUALITY ISSUE 5 0.0000
989 EYE PAIN 2 0.0000
990 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
991 ASTHMA 4 0.0000
992 EMOTIONAL DISTRESS 4 0.0000
993 TOXICITY TO VARIOUS AGENTS 4 0.0000
994 PSORIASIS 3 0.0000